The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
BioCryst Pharmaceuticals, Inc(NASDAQ:BCRX) 
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; Mundesine, an ora...
Website: http://www.biocryst.com
Founded: 1986
Full Time Employees: 140
Sector: Healthcare
Industry: Biotechnology
BioCryst Pharmaceuticals Days Payable Outstanding ttm (DPO)
BioCryst Pharmaceuticals Days Receivable Outstanding ttm (DSO)
BioCryst Pharmaceuticals Days Inventory Outstanding ttm (DIO)
BioCryst Pharmaceuticals Op Cashflow Per Share ttm
BioCryst Pharmaceuticals Free Cashflow Per Share ttm
BioCryst Pharmaceuticals Cash Per Share ttm
BioCryst Pharmaceuticals P/S ratio ttm
BioCryst Pharmaceuticals (GAAP) P/E ratio ttm
BioCryst Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.